Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06219473Phase 4Not yet recruiting
Phase 4, randomised, open-label trial (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Pink Aesthetic Score at 6 Months. Planned start Feb 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06219473.